Amara Raja Energy & Mobility Limited (ARE&M), formerly Amara Raja Batteries Limited, is the flagship company of the Andhra Pradesh-based Amara Raja Group, founded by Dr. Ramachandra N. Galla in 1985 and now led by Chairman & Managing Director Jayadev Galla. ARE&M is one of India’s two dominant lead-acid storage battery manufacturers — alongside Exide Industries — in a structurally duopolistic industry with high barriers to entry (capital intensity, recycling infrastructure, OEM qualification cycles, and distribution reach).

The company’s Automotive division sells under the flagship Amaron brand (memorably marketed as “Lasts Long, Really Long”) plus PowerZone, serving both the OEM channel — with long-standing relationships spanning Maruti Suzuki, Hyundai, Tata Motors, Mahindra & Mahindra, Honda, Renault-Nissan, Bajaj Auto and Royal Enfield — and a vast pan-India aftermarket/replacement retail network. The Industrial division manufactures VRLA (Valve Regulated Lead Acid) batteries under PowerStack, Amaron Sleek, Amaron Volt, Amaron Quanta, Amaron Brute and Genpro brands for UPS, telecom, railways, solar, defence, and power/oil & gas customers; the company was a pioneer of VRLA technology in India and states it powers roughly every second telecom tower in the country. Products are exported to 70+ countries across the Indian Ocean Rim.

The strategic growth vector is the New Energy business, housed under Amara Raja Advanced Cell Technologies (ARACT) and marketed as the “Amara Raja Giga Corridor.” The company is investing an announced ₹9,500 crore over roughly a decade to build up to 16 GWh of lithium-ion cell capacity plus ~5 GWh of pack assembly at a 262-acre site in Divitipally, Telangana, alongside the “ePositive Energy Labs” research and innovation hub in Hyderabad. As of the June 2026 quarter, cumulative investment in ARACT stood at roughly ₹1,650 crore; a 60 MWh Customer Qualification Plant (CQP), representing a further ₹500 crore of that spend, was commissioned in July 2026 to validate cylindrical NMC and LFP cell chemistries with customers ahead of the first commercial gigafactory line (targeted for FY27, initially ~4 GWh), with an initial focus on two-wheelers and stationary energy storage rather than passenger-vehicle customisation. The company also holds a stake in Log-9 Materials and has a strategic tie-up with Ather Energy and a partnership with Nuvation Energy to localise high-voltage battery management systems (BMS). The company terminated its long-standing joint-venture shareholder agreement with Johnson Controls effective April 2019 and has operated independently in lead-acid technology since.

Data note: unless stated otherwise, all financial figures in this report are on a standalone basis (source: Screener.in / company filings), which captures the legacy Automotive and Industrial battery business; ARACT/New Energy is a separate subsidiary and is valued independently in the SOTP section.

Revenue has compounded at roughly 11% over ten years and 13% on a trailing-twelve-month basis, but profitability has been far less consistent: operating margin has compressed from the high-teens a decade ago to 11% currently, largely on lead cost inflation and rising New Energy-related opex/depreciation, leaving ten-year profit CAGR at just 3% and three-year/TTM profit growth actually negative (-6%). Cash conversion has stayed strong throughout — CFO/Operating-Profit has run at 100%+ in the last three years — and the balance sheet remains “almost debt free” per Screener’s own screen, with gross borrowings of just ₹373 crore against reserves of ₹8,142 crore in FY26.

Profit & Loss (Standalone, ₹ Cr)

Balance Sheet (Standalone, ₹ Cr)

Cash Flow (Standalone, ₹ Cr)

Q1 FY27 (Jun 2026) print: standalone sales of ₹4,041 crore grew a strong 20.6% YoY (vs ₹3,350 crore in Q1 FY26), though OPM slipped further to 10% and standalone net profit came in at ₹203 crore (EPS ₹11.08). On a consolidated basis (which folds in ARACT’s New Energy losses), total income rose 23.8% YoY to approximately ₹4,235 crore while consolidated PAT of ₹190.94 crore was up 15.9% YoY but down 39.3% QoQ from an other-income-boosted March 2026 quarter. The company deployed a further ₹150 crore into ARACT during the quarter, taking cumulative New Energy investment to ₹1,650 crore.

This DCF values the standalone legacy Automotive + Industrial battery business only (a 10-year FCFF model, WACC 12%, terminal growth 5%); the New Energy/Li-ion Gigafactory is deliberately excluded here and valued separately under SOTP, since it is pre-commercial, loss-making, and not amenable to a standard growing-perpetuity DCF. Revenue growth is modelled tapering from 10% to 5% over the decade as the replacement/industrial mix matures; EBITDA margin is assumed to gradually recover from a cyclically depressed 11% (FY26) toward 14% as lead cost pressure normalises and operating leverage plays out; capex is held slightly above depreciation to fund steady growth capacity.

The striking result is that the core-business DCF value of ≈₹863 per share lands almost exactly on the current market price of ₹864 — i.e., the market currently appears to be pricing ARE&M purely as a maturing lead-acid battery compounder and assigning close to zero standalone value to the ₹9,500 crore New Energy/Li-ion optionality. That gap is the core of the investment debate addressed in the SOTP section below.

ARE&M’s most direct comparable is Exide Industries, the only other large-scale organised lead-acid battery player in India (also building its own Li-ion JV/gigafactory via Exide Energy Solutions). Broader “auto ancillary” peers such as Samvardhana Motherson, Bosch, Uno Minda and Endurance Technologies are diversified, higher-multiple businesses that are useful only as a sector-multiple ceiling reference, not a like-for-like comparison.

ARE&M trades at a meaningful discount to Exide (roughly 20x vs ~28–31x trailing earnings) despite a historically comparable or superior return profile, largely reflecting the sharper margin compression seen in FY26 (OPM down to 11% vs Exide’s steadier ~10–11% on a larger base) and the cash drag from funding New Energy capex out of operating cash flow. Applying a conservative re-rating band of 18x–22x to TTM EPS of ₹53.50 (still a discount to Exide) implies a relative-valuation fair value range of approximately ₹963–₹1,177 per share — meaningfully above both CMP and the pure core-business DCF, and consistent with several sell-side 12-month targets clustered in the ₹919–₹1,120 band.

Reported book value stands at ₹446 per share (FY26), against a current price-to-book of ~1.9x. Fixed assets plus capital-work-in-progress of ₹4,517 crore (FY26) understate true replacement cost given multi-decade-old integrated manufacturing complexes (including the “world’s largest integrated MVRLA plant” at Yadamarri, Chittoor) and inflation in plant/land costs since original acquisition; a modest replacement-cost markup of 15–20% on net fixed assets, added to the ₹2,585 crore investment book (which includes the ARACT stake, treasury investments and other strategic holdings) and netted against working-capital and other liabilities, points to an adjusted NAV of approximately ₹500–₹530 per share. This NAV effectively functions as a hard floor valuation for the legacy business — a scenario where the company is worth little more than its net tangible assets, i.e., no going-concern earnings premium and no credit for New Energy.

EPV strips out all growth assumptions and simply capitalises current, normalised after-tax operating earnings at the cost of capital — a useful “no-growth floor” check against the DCF’s growth-embedded value. Using FY26 standalone EBIT of ₹1,003 crore (Operating Profit ₹1,551 Cr less Depreciation ₹548 Cr), taxed at 26% to a NOPAT of ₹742 crore, and capitalised at the 12% WACC:

At ≈₹387/share, EPV sits well below both the current price and book value, implying the market is confidently pricing in continued earnings growth from today’s depressed margin base rather than valuing ARE&M as a static, no-growth annuity. This is the natural “bear-case floor” in the valuation stack — a level the stock would only approach if margins failed to recover and growth stalled entirely.

The clearest lens on ARE&M today is as two businesses bolted together: a mature, cash-generative lead-acid duopoly funding an early-stage, capital-intensive bet on lithium-ion cells. SOTP values each piece on its own terms rather than forcing a single blended multiple or DCF.

The SOTP range of roughly ₹950–₹1,000 per share deliberately values the Gigafactory conservatively at close to invested capital rather than on a full replacement-cost or discounted-cash-flow basis (which would require assuming successful ramp-up, customer qualification, and PLI incentive realisation — all still unproven as of mid-2026). Even on this cautious treatment, SOTP sits ~10–16% above CMP, converging with the ₹919–₹1,120 range of sell-side 12-month price targets and the ₹850–₹950 “accumulation range” flagged by independent SOTP research on the stock. A bull case that credits the Gigafactory with full replacement value once the 4 GWh commercial line is operational (targeted FY27) would push SOTP meaningfully higher still — the basis for the bull scenario in Section 9.

Promoter holding stepped up sharply from 28.06% to 32.86% in the March 2024 quarter (a scheme-of-arrangement related restructuring) and has held flat since. FII ownership has been on a steady multi-quarter decline — from 24.64% in September 2023 to 17.34% by June 2026 — while DII ownership has been comparatively more stable, running in the 14–17% band, and public/retail ownership has climbed to 34.50%, the highest in the dataset, alongside a rising shareholder count (over 8.18 lakh as of June 2026, more than 10x the ~60,000 seen a decade ago).

Top Identified Holders (as of latest available filings)

Beyond Nalanda Capital (the largest non-promoter, non-index shareholder) and the promoter entity, individual scheme-level names below the top holder are not reliably available from public aggregator sources at time of writing; readers seeking scheme-wise or FPI-wise granularity should consult the company’s BSE/NSE shareholding pattern filings directly. Notable mutual fund schemes with disclosed exposure include Franklin India Small Cap Fund, Nippon India Multi Cap Fund, ICICI Prudential Multi-Asset Fund, Franklin India Flexi Cap Fund and Bandhan Small Cap Fund, though these figures represent the scheme’s exposure and may lag the live quarter.

The ownership trend — falling FII exposure and rising retail participation over the past three years — is broadly consistent with a stock whose earnings have plateaued and whose re-rating case now rests on an unproven, multi-year New Energy build-out; a reacceleration in FII buying alongside confirmed Gigafactory delivery would be a meaningful sentiment catalyst.